Company intelligence / Profile preview

Pandorum Technologies

Bengaluru, Karnataka, Indiapandorum.com ↗

Ownership: Private
Employees: ~75
Development stage: Other

Overview

Pandorum Technologies develops proprietary regenerative medicine platforms focused on creating functional human tissues such as bioengineered corneas and livers. The company also works on cell-free exosome-based therapies targeting post-trauma lung repair. Most programs are at preclinical or early translational stages with no reported late-stage clinical results yet.

Therapeutic areas: GastroenterologyPulmonologyOphthalmology
Modalities: Stem cell-derived exosomes (cell-free therapies)Mesenchymal stem cells (MSC)Bioengineered tissues/organoids (cornea, liver)Biomaterials for tissue engineering3D bioprinting and self assembly of tissues
Industry: Biotech

Drug pipeline

1 asset

Kuragenx

Preclinical

Beyond the preview

Go deeper on Pandorum Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pandorum Technologies.

Explore the full profile